Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy

It is a matter of current interest which rifaximin-α regimens in patients with liver cirrhosis and minimal hepatic encephalopathy are the most efficient. Study objective: to evaluate the effect of various rifaximin-α regimens for 12 months on clinical and laboratory parameters and quality of life in...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Igor G. Bakulin, Kristina N. Ivanova, Elena Y. Eremina, Natalya V. Marchenko
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-10-01
Edice:	Diagnostics
Témata:	liver cirrhosis hepatic encephalopathy minimal hepatic encephalopathy rifaximin-α
On-line přístup:	https://www.mdpi.com/2075-4418/13/20/3239
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!